|
"tsai kk"的相關文件
顯示項目 1-25 / 35 (共2頁)
1 2 > >>
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2025-04 |
Emerging roles of ACTL6A as an oncogenic hub: Transcriptional regulation and beyond
|
Tsai, KK;Cheng, LH;Hsu, CC;Yang, PM;Chuu, CP |
| 國家衛生研究院 |
2024-01-26 |
ASPM stabilizes the NOTCH intracellular domain 1 and promotes oncogenesis by blocking FBXW7 binding in hepatocellular carcinoma cells
|
Chan, TS;Cheng, LH;Hsu, CC;Yang, PM;Liao, TY;Hsieh, HY;Lin, PC;HuangFu, WC;Chuu, CP;Tsai, KK |
| 國家衛生研究院 |
2023-06-29 |
Oncogenic ASPM is a regulatory hub of developmental and stemness signaling in cancers
|
Tsai, KK;Bae, BI;Hsu, CC;Cheng, LH;Shaked, Y |
| 國家衛生研究院 |
2023-03 |
ASPM activates Hedgehog and Wnt signaling to promote small cell lung cancer stemness and progression
|
Cheng, LH;Hsu, CC;Tsai, HW;Liao, WY;Yang, PM;Liao, TY;Hsieh, HY;Chan, TS;Tsai, KK |
| 國家衛生研究院 |
2022-05-26 |
Screening of organoids derived from patients with breast cancer implicates the repressor NCOR2 in cytotoxic stress response and antitumor immunity
|
Tsai, KK;Huang, SS;Northey, JJ;Liao, WY;Hsu, CC;Cheng, LH;Werner, ME;Chuu, CP;Chatterjee, C;Lakins, JN;Weaver, VM |
| 國家衛生研究院 |
2022-03 |
Inhibition of KDM4C/c-Myc/LDHA signalling axis suppresses prostate cancer metastasis via interference of glycolytic metabolism
|
Lin, CY;Wang, BJ;Fu, YK;Huo, C;Wang, YP;Chen, BC;Liu, WY;Tseng, JC;Jiang, SS;Sie, ZL;Tsai, KK;Yuh, CH;Wang, WC;Kung, HJ;Chuu, CP |
| 國家衛生研究院 |
2021-06-22 |
A Novel Invadopodia-Specific Marker for Invasive and Pro-Metastatic Cancer Stem Cells [Erratum:Frontiers in Oncology. 2021 May 31;11:Article number 638311.]
|
Huang, SS;Liao, WY;Hsu, CC;Chan, TS;Liao, TY;Yang, PM;Chen, LT;Sung, SY;Tsai, KK |
| 國家衛生研究院 |
2021-05-31 |
A novel invadopodia-specific marker for invasive and pro-metastatic cancer stem cells
|
Huang, SS;Liao, WY;Hsu, CC;Chan, TS;Liao, TY;Yang, PM;Chen, LT;Sung, SY;Tsai, KK |
| 國家衛生研究院 |
2021-03-26 |
A multi-mode Wnt- and stemness-regulatory module dictated by FOXM1 and ASPM isoform I in gastric cancer[Erratum:Gastric Cancer. 2021 Jan 29;Article in Press.]
|
Hsu, CC;Liao, WY;Chang, KY;Chan, TS;Huang, PJ;Chiang, CT;Shan, YS;Cheng, LH;Liao, TY;Tsai, KK |
| 國家衛生研究院 |
2021-01-29 |
A multi-mode Wnt- and stemness-regulatory module dictated by FOXM1 and ASPM isoform I in gastric cancer
|
Hsu, CC;Liao, WY;Chang, KY;Chan, TS;Huang, PJ;Chiang, CT;Shan, YS;Cheng, LH;Liao, TY;Tsai, KK |
| 國家衛生研究院 |
2020-03-10 |
Dishevelled 1-regulated superpotent cancer stem cells mediate wnt heterogeneity and tumor progression in hepatocellular carcinoma
|
Liao, WY;Hsu, CC;Chan, TS;Yen, CJ;Chen, WY;Pan, HW;Tsai, KK |
| 國家衛生研究院 |
2020-01 |
A multicenter, phase I/II trial of biweekly S-1, leucovorin, oxaliplatin and gemcitabine in metastatic pancreatic adenocarcinoma–TCOG T1211 study
|
Chiang, NJ;Tsai, KK;Hsiao, CF;Yang, SH;Hsiao, HH;Shen, WC;Hsu, C;Lin, YL;Chen, JS;Shan, YS;Chen, LT |
| 國家衛生研究院 |
2019-11-13 |
Histone demethylase KDM4C stimulates the proliferation of prostate cancer cells via activation of AKT and c-Myc
|
Lin, CY;Wang, BJ;Chen, BC;Tseng, JC;Jiang, SS;Tsai, KK;Shen, YY;Yuh, CH;Sie, ZL;Wang, WC;Kung, HJ;Chuu, CP |
| 國家衛生研究院 |
2019-08-29 |
The differential distributions of ASPM isoforms and their roles in Wnt signaling, cell cycle progression, and pancreatic cancer prognosis
|
Hsu, CC;Liao, WY;Chan, TS;Chen, WY;Lee, CT;Shan, YS;Huang, PJ;Hou, YC;Li, CR;Tsai, KK |
| 國家衛生研究院 |
2019-07 |
Targeting the interplay between cancer fibroblasts, mesenchymal stem cells, and cancer stem cells in desmoplastic cancers
|
Chan, TS;Shaked, Y;Tsai, KK |
| 國家衛生研究院 |
2019-05-17 |
Next viable routes to targeting pancreatic cancer stemness: Learning from clinical setbacks
|
Tsai, KK;Chan, TS;Shaked, Y |
| 國家衛生研究院 |
2018-12 |
ACTL6a promotes metastasis and predicts poor prognosis of prostate cancer via regulation of YAP and cancer stemness
|
Chuu, CP;Lin, CY;Huang, SH;Liao, WY;Tsai, KK |
| 國家衛生研究院 |
2018-11-02 |
ASPM promotes prostate cancer stemness and progression by augmenting Wnt-Dvl-3-beta-catenin signaling [Erratum: Oncogene. 2018 Sep 28;Article in Press.]
|
Pai, VC;Hsu, CC;Chan, TS;Liao, WY;Chuu, CP;Chen, WY;Li, CR;Lin, CY;Huang, SP;Chen, LT;Tsai, KK |
| 國家衛生研究院 |
2018-11 |
Targeting PTX3 can prevent drug-resistant cancer progression
|
Wang, JM;Chi, JY;Hsiao, YW;Li, CF;Lo, YC;Lin, ZY;Hong, JY;Liu, YM;Han, X;Wang, SM;Chen, BK;Tsai, KK |
| 國家衛生研究院 |
2018-10 |
Multicenter, phase II trial of biweekly S-1, leucovorin (LV), oxaliplatin and gemcitabine (SLOG) in metastatic pancreatic adenocarcinoma (mPDAC): Final report of TCOG T1211 study
|
Chiang, NJ;Tsai, KK;Chen, JS;Yang, SH;Hsiao, HH;Shan, YS;Chen, LT |
| 國家衛生研究院 |
2018-09-28 |
ASPM promotes prostate cancer stemness and progression by augmenting Wnt-Dvl-3-beta-catenin signaling
|
Pai, VC;Hsu, CC;Chan, TS;Liao, WY;Chuu, CP;Chen, WY;Li, CR;Lin, CY;Hwang, SP;Chen, LT;Tsai, KK |
| 國家衛生研究院 |
2017-11 |
Stress stimuli induce cancer-stemness gene expression via Sp1 activation leading to therapeutic resistance in glioblastoma
|
Chang, KY;Huang, CT;Hsu, TI;Hsu, CC;Liu, JJ;Chuang, CK;Hung, JJ;Chang, WC;Tsai, KK;Chuang, JY |
| 國家衛生研究院 |
2016-12 |
Metronomic chemotherapy prevents therapy-induced stromal activation and induction of tumor-initiating cells
|
Chan, TS;Hsu, CC;Pai, VC;Liao, WY;Huang, SS;Tan, KT;Yen, CJ;Hsu, SC;Chen, WY;Shan, YS;Li, CR;Lee, MT;Jiang, KY;Chu, JM;Lien, GS;Weaver, VM;Tsai, KK |
| 國家衛生研究院 |
2016-12 |
NCoR2 mediates death-resistance and mechano-regulation of glioblastoma multiforme
|
Kaushik, S;Tsai, KK;Barnes, JM;Phillips, JJ;Weaver, VM |
| 國家衛生研究院 |
2016-02 |
Phase I trial of biweekly S-1, leucovorin, oxaliplatin, and gemcitabine (the SLOG regimen) in metastatic pancreatic adenocarcinoma (mPDAC)
|
Chiang, NJ;Tsai, KK;Chen, JS;Yang, SH;Hsu, C;Shan, YS;Chen, LT |
顯示項目 1-25 / 35 (共2頁)
1 2 > >>
每頁顯示[10|25|50]項目
|
